Rh disease may get all the headlines, but immunologic reactions to the Kell antigen can be just as lethal to a K1-positive fetus—if not more so.
Sep 1, 2008
By:Kenneth J. Moise, Jr., MD
Immunological reactions to the Kell antigen can cause as much damage to the unborn as Rh disease.
 |
Although serial amnioreduction is still widely used to treat this dangerous condition, a recent randomized trial found that when compared to amnioreduction at 15 to 26 weeks, overall perinatal survival is higher with laser ablation, which tries to reverse the disease process.
Dec 1, 2006
By:Anthony Johnson, DO, Kenneth J. Moise, Jr., MD
Although serial amnioreduction is still widely used to treat this dangerous condition, a recent randomized trial found that when compared to amnioreduction at 15 to 26 weeks, overall perinatal survival is higher with laser ablation, which tries to reverse the disease process.
|
Pregnant patients are more likely than ever to ask about stem cells and umbilical cord blood banking. In this article, an expert provides an update on the pros and cons of cord blood banking—and the controversy over private versus public banks—to help you counsel appropriately.
Apr 15, 2006
By:Kenneth J. Moise, Jr., MD
Pregnant patients are more likely than ever to ask about stem cells and umbilical cord blood banking. In this article, an expert provides an update on the pros and cons of cord blood banking, and the controversy over private versus public banks, to help you counsel appropriately.
|
May 1, 2004
By:Kenneth J. Moise, Jr., MD
Once a common cause of perinatal death, Rh disease is now quite rare in pregnant women, thanks in large part to advances in U/S and DNA technology. But the fact that roughly 7 out of every 1,000 liveborn infants are delivered by Rh-sensitized women emphasizes the need for more vigorous preventive efforts and up-to-date management skills.
|
| 
Practice Tools
